MetLife Investment Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $632K | Buy |
19,310
+871
| +5% | +$31.4K | ﹤0.01% | 1778 |
|
|
2026
Q1 | $652K | Sell |
18,439
-136
| -0.7% | -$5.53K | ﹤0.01% | 1624 |
|
|
2025
Q4 | $754K | Hold |
18,575
| – | – | ﹤0.01% | 1588 |
|
|
2025
Q3 | $874K | Hold |
18,575
| – | – | ﹤0.01% | 1530 |
|
|
2025
Q2 | $967K | Sell |
18,575
-32
| -0.2% | -$1.76K | 0.01% | 1333 |
|
|
2025
Q1 | $1.12M | Sell |
18,607
-279
| -1% | -$18K | 0.01% | 1306 |
|
|
2024
Q4 | $1.29M | Buy |
18,886
+1,250
| +7% | +$87.1K | 0.01% | 1290 |
|
|
2024
Q3 | $1.27M | Hold |
17,636
| – | – | 0.01% | 1258 |
|
|
2024
Q2 | $1.22M | Buy |
17,636
+1,887
| +12% | +$138K | 0.01% | 1241 |
|
|
2024
Q1 | $1.26M | Sell |
15,749
-414
| -3% | -$36.9K | 0.01% | 1169 |
|
|
2023
Q4 | $1.77M | Hold |
16,163
| – | – | 0.01% | 994 |
|
|
2023
Q3 | $1.63M | Hold |
16,163
| – | – | 0.01% | 999 |
|
|
2023
Q2 | $2.2M | Buy |
16,163
+836
| +5% | +$102K | 0.02% | 897 |
|
|
2023
Q1 | $1.59M | Hold |
15,327
| – | – | 0.01% | 996 |
|
|
2022
Q4 | $1.36M | Hold |
15,327
| – | – | 0.01% | 1063 |
|
|
2022
Q3 | $1.23M | Buy |
15,327
+307
| +2% | +$29K | 0.01% | 1087 |
|
|
2022
Q2 | $1.44M | Sell |
15,020
-369
| -2% | -$44.3K | 0.01% | 1037 |
|
|
2022
Q1 | $2.29M | Buy |
15,389
+5,522
| +56% | +$771K | 0.01% | 939 |
|
|
2021
Q4 | $1.4M | Sell |
9,867
-590
| -6% | -$83.6K | 0.01% | 989 |
|
|
2021
Q3 | $1.37M | Hold |
10,457
| – | – | 0.01% | 985 |
|
|
2021
Q2 | $1.44M | Hold |
10,457
| – | – | 0.01% | 998 |
|
|
2021
Q1 | $1.37M | Sell |
10,457
-933
| -8% | -$112K | 0.01% | 994 |
|
|
2020
Q4 | $1.28M | Hold |
11,390
| – | – | 0.01% | 1023 |
|
|
2020
Q3 | $896K | Sell |
11,390
-1,063
| -9% | -$86.7K | 0.01% | 1079 |
|
|
2020
Q2 | $896K | Buy |
12,453
+1,053
| +9% | +$73.3K | 0.01% | 1080 |
|
|
2020
Q1 | $653K | Hold |
11,400
| – | – | 0.01% | 1073 |
|
|
2019
Q4 | $1.27M | Sell |
11,400
-887
| -7% | -$94.5K | 0.01% | 975 |
|
|
2019
Q3 | $1.18M | Hold |
12,287
| – | – | 0.01% | 990 |
|
|
2019
Q2 | $1.05M | Buy |
12,287
+604
| +5% | +$49.7K | 0.01% | 1078 |
|
|
2019
Q1 | $972K | Hold |
11,683
| – | – | 0.01% | 1098 |
|
|
2018
Q4 | $750K | Hold |
11,683
| – | – | 0.01% | 1137 |
|
|
2018
Q3 | $926K | Hold |
11,683
| – | – | 0.01% | 1168 |
|
|
2018
Q2 | $855K | Sell |
11,683
-1,688
| -13% | -$115K | 0.01% | 1094 |
|
|
2018
Q1 | $847K | Hold |
13,371
| – | – | 0.01% | 1078 |
|
|
2017
Q4 | $682K | Buy |
+13,371
| New | +$696K | 0.01% | 1219 |
|
Other funds holding CNMD
ICM
MetLife Investment Management's CNMD Position: Q2 2026 in Review
MetLife Investment Management increased its CONMED (CNMD) stake by 4.7% in Q2 2026, buying an estimated $31.4K and bringing the position to 19,310 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.
MetLife Investment Management first reported a position in CNMD in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.29M in Q1 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- MetLife Investment Management held 19,310 shares of CONMED worth $632K as of Q2 2026.
- MetLife Investment Management bought 871 CONMED shares in Q2 2026, an estimated $31.4K.
- CONMED made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1778 holding.
- MetLife Investment Management first reported a position in CONMED in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's CONMED position peaked at $2.29M in Q1 2022.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.